CBTi

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87

At 6 weeks, participants receiving CBTi had significantly greater reductions in depression severity (HAM-D) compared to attention control, with a large effect size (d = 0.87), even before beginning PT

Effect: improvement; d = 0.87